Kaleida Health Diagnosis Related Group (DRG) - Readmission Quality Outcomes - Oct 2016 to Sep 2019

Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for Kaleida Health located at 445 Tremont St, North Tonawanda, NY, 14120 & includes data from NPIs 1366489221, 1104956358


Get Dexur’s Personalized Hospital Specific Presentation on Quality, Safety, Compliance & Education

*Readmission Rate is calculated from October 2016 to August 2019 and all other Quality Outcomes are calculated from October 2016 to September 2019.

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

Total Hospitalizations (Oct 2016 to Sep 2019) Total Hospitalizations After Exclusion Total Users Readmission Rate(%) New York Total Hospitalizations (Oct 2016 to Sep 2019) New York Total Hospitalizations After Exclusion New York Total Users New York Readmission Rate(%) National Total Hospitalizations ( Oct 2016 to Sep 2019) National Total Hospitalizations After Exclusion National Total Users National Readmission Rate(%)
All Inpatient 604 589
Surgical 44 43
Non Surgical 560 546
General Medicine 147 141
Cardiovascular 143 139
Pulmonology 135 133
Orthopedics 46 46
Gastroenterology & Endocrinology 45 44
Urology 44 43
Neurology 16 16
Oncology & Hematology 14 14

General Medicine   |   Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

Total Hospitalizations (Oct 2016 to Sep 2019) Total Hospitalizations After Exclusion Total Users Readmission Rate(%) New York Total Hospitalizations (Oct 2016 to Sep 2019) New York Total Hospitalizations After Exclusion New York Total Users New York Readmission Rate(%) National Total Hospitalizations ( Oct 2016 to Sep 2019) National Total Hospitalizations After Exclusion National Total Users National Readmission Rate(%)
Septicemia Or Severe Sepsis
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC)
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC)
Nutritional And Miscellaneous Metabolic Disorders
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC)
Cellulitis
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC)

Cardiovascular   |   Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

Total Hospitalizations (Oct 2016 to Sep 2019) Total Hospitalizations After Exclusion Total Users Readmission Rate(%) New York Total Hospitalizations (Oct 2016 to Sep 2019) New York Total Hospitalizations After Exclusion New York Total Users New York Readmission Rate(%) National Total Hospitalizations ( Oct 2016 to Sep 2019) National Total Hospitalizations After Exclusion National Total Users National Readmission Rate(%)
Heart Failure And Shock
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC)
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC)
DRG 293: HEART FAILURE AND SHOCK WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC)
Cardiac Arrhythmia And Conduction Disorders
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC)
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC)

Pulmonology   |   Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

Total Hospitalizations (Oct 2016 to Sep 2019) Total Hospitalizations After Exclusion Total Users Readmission Rate(%) New York Total Hospitalizations (Oct 2016 to Sep 2019) New York Total Hospitalizations After Exclusion New York Total Users New York Readmission Rate(%) National Total Hospitalizations ( Oct 2016 to Sep 2019) National Total Hospitalizations After Exclusion National Total Users National Readmission Rate(%)
Chronic Obstructive Pulmonary Disease
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC)
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC)
Pulmonary Edema And Respiratory Failure
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE
Simple Pneumonia And Pleurisy
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC)
Respiratory Infections And Inflammations

Orthopedics   |   Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

Total Hospitalizations (Oct 2016 to Sep 2019) Total Hospitalizations After Exclusion Total Users Readmission Rate(%) New York Total Hospitalizations (Oct 2016 to Sep 2019) New York Total Hospitalizations After Exclusion New York Total Users New York Readmission Rate(%) National Total Hospitalizations ( Oct 2016 to Sep 2019) National Total Hospitalizations After Exclusion National Total Users National Readmission Rate(%)
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC)

Gastroenterology & Endocrinology   |   Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

Total Hospitalizations (Oct 2016 to Sep 2019) Total Hospitalizations After Exclusion Total Users Readmission Rate(%) New York Total Hospitalizations (Oct 2016 to Sep 2019) New York Total Hospitalizations After Exclusion New York Total Users New York Readmission Rate(%) National Total Hospitalizations ( Oct 2016 to Sep 2019) National Total Hospitalizations After Exclusion National Total Users National Readmission Rate(%)
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC)
Diabetes

Urology   |   Back to Top

Data with Symbol is only for Dexur Customers. Get in touch with us to know more.

Total Hospitalizations (Oct 2016 to Sep 2019) Total Hospitalizations After Exclusion Total Users Readmission Rate(%) New York Total Hospitalizations (Oct 2016 to Sep 2019) New York Total Hospitalizations After Exclusion New York Total Users New York Readmission Rate(%) National Total Hospitalizations ( Oct 2016 to Sep 2019) National Total Hospitalizations After Exclusion National Total Users National Readmission Rate(%)
Renal Failure
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC)
Kidney And Urinary Tract Infections
Other Kidney And Urinary Tract Diagnoses